Spotlight on Telotristat Ethyl for the Treatment of Carcinoid Syndrome Diarrhea: Patient Selection and Reported Outcomes

Cancer Management and Research - New Zealand
doi 10.2147/cmar.s181439
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

Developments in the Treatment of Carcinoid Syndrome &Ndash; Impact of Telotristat

Therapeutics and Clinical Risk Management
2018English

Updated Evaluation of Dupilumab in the Treatment of Asthma: Patient Selection and Reported Outcomes

Therapeutics and Clinical Risk Management
2020English

Spotlight on Spironolactone Oral Suspension for the Treatment of Heart Failure: Focus on Patient Selection and Perspectives

Vascular Health and Risk Management
2019English

Patient-Reported Experience and Outcomes From Orthodontic Treatment

Journal of Orthodontics
Orthodontics
2020English

Radiograph View Influences Patient Selection and Patient-Reported Outcomes in Injection Therapy for Knee Osteoarthritis

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2016English

The Future of Measuring Patient-Reported Outcomes in Rheumatology: Patient-Reported Outcomes Measurement Information System (PROMIS)

Arthritis Care and Research
Rheumatology
2011English

Parachlorophenylalanine Treatment in Carcinoid Syndrome.

BMJ
1970English

Comments on Watson, the Microbiome of Children, and Patient-Reported Outcomes

Clinical Therapeutics
Pharmacology
2016English

Evaluating Vandetanib in the Treatment of Medullary Thyroid Cancer: Patient-Reported Outcomes

Cancer Management and Research
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy